IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krishnapillai, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krishnapillai, V.
Infect Immun. 1971 September; 4(3): 177-188
Copyright © 1971 American Society for Microbiology. All Rights Reserved.

Uridinediphosphogalactose-4-Epimerase Deficiency in Salmonella typhimurium and Its Correction by Plasmid-Borne Galactose Genes of Escherichia coli K-12: Effects on Mouse Virulence, Phagocytosis, and Serum Sensitivity

V. Krishnapillai1

a Department of Medical Microbiology, Stanford University School of Medicine, Palo Alto, California 94305

ABSTRACT

The synthesis of smooth lipopolysaccharide (LPS) in relation to mouse virulence and resistance to serum bactericidal activity in vitro and to rapid intravenous clearance in vivo was studied in Salmonella typhimurium by using a virulent [median lethal dose (LD50) = 102], smooth, and genetically marked strain, a uridinediphosphogalactose epimerase-deficient mutant of it which was, therefore, rough, and a derivative of the mutant made smooth again by acquisition of the galactose-positive genes of Escherichia coli. The mutant was of reduced virulence (LD50 = 106) but the smooth derivative regained the virulence character typical of the parent. The non-smooth phenotype also made the mutant, but not the smooth relatives (parent and derivative), susceptible to serum bactericidal activity and also to rapid intravenous clearance by phagocytosis by the liver. The mutant was similarly treated by germ-free mice (expected to be relatively free of opsonizing antibodies). The clearance of the mutant could be impaired by prior intravenous inoculation of homologous bacteria or their LPS but was reversible by preopsonization of the second inoculum with nonimmune mouse serum, suggesting that the initial inoculum preempted the opsonizing antibodies. Independent evidence of clearance specificity was also provided in mixed inoculum experiments on impaired mice by the rapid clearance of an antigenically unrelated heptose-deficient mutant while maintaining the decelerated clearance of the epimerase mutant. The latter, however, was converted to accelerated clearance by the intravenous inoculation during the impaired state of anti-epimerase mutant immune mouse serum.


FOOTNOTES

1 Present address: Department of Genetics, Faculty of Science, Monash University, Clayton 3168, Victoria, Australia.


Infect Immun. 1971 September; 4(3): 177-188
Copyright © 1971 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1971 by the American Society for Microbiology. All rights reserved.